Abstract:Objective: A sensitive and rapid ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was successfully applied to the determination of 10 alkaloids in beagle dog plasma following a single oral dose of Xiatianwu capsules and enteric-coated capsules, with theophylline serving as the internal standard (IS). Methods: Plasma samples were preprocessed using liquid-liquid extraction (LLE) with ethyl acetate ahead to separation using a gradient elution procedure on a Waters ACQUITY UPLC HSS T3 column (1.8 μm, 100 × 2.1 mm). The mobile phase was composed of 0.1% formic acid solution and acetonitrile at the flow rate of 0.3 ml/min. Multiple reaction monitoring (MRM) was used to determine the analytes in the positive ion mode. Results: The calibration curves for 10 analytes demonstrated a high degree of linearity (r ≥ 0.9920). The lower limit of quantification (LLOQ) values for 10 alkaloids were all more than 1.074 ng/ml, and matrix effects varied from 94.25% to 106.15%. The mean extraction recovery of quality control samples at low (LQC), medium (MQC) and high (HQC) concentrations, as well as IS, was all more than 76.60%. The intra-day and inter-day precision (RSD) also satisfied the requirement. Simultaneously, the variation of assay accuracies (RE) was between 13.05% and 9.38%. Conclusion: The test was validated in accordance with regulatory bioanalytical guidelines and was found to be suitable for use in a pharmacokinetic investigation of these compounds in beagle dogs after oral administration of Xiatianwu general capsules and enteric-coated capsules. The Cmax of 10 alkaloids ranged from 52.61 to 192.46 ng/ml after oral administration of Xiatianwu capsules, and from 67.50 to 247.36 ng/ml. The Tmax was between 0.59 and 1.33 h of Xiatianwu capsules, and between 1.08 and 2.00 h of enteric-coated capsules. The t1/2 ranged from 3.18 to 7.47 h of general capsules, and from 6.01 to 11.36 h. AUC0-t ranged from 181.06 to 722.74 ng·h/ml of Xiatianwu capsules, and from 275.03 to 884.17 ng·h/ml of enteric-coated capsules. The Cmax of enteric-coated capsules were significantly increased except for tetrahydropalmatine and berberine. Tmax of general capsules were less than 1 h, and of enteric-coated capsules were less than 2 h. The t1/2 of dehydrocorydaline, palmatine, tetrahydrojatrorrhizine, jatrorrhizine and coptisine in enteric-coated capsules was longer than that in ordinary capsule. The AUC0-t and AUC0-∞ of bicuculline, dehydrocorydaline, protopine, magnoflorine, tetrahydrojatrorrhizine, jatrorrhizine, berberine and coptisine were all significantly higher in enteric-coated capsules.

[Metabolic Regulation of Phenylethanoid Glycosides from Herba Cistanches in Dogs' Gastrointestine].

PREPARATIVE ISOLATION AND PURIFICATION OF PHENYLETHANOID GLYCOSIDES FROM THE EXTRACT OF FAECES OF BEAGLE DOGS BY HIGH-SPEED COUNTERCURRENT CHROMATOGRAPHY

Screening and Identification of Three Typical Phenylethanoid Glycosides Metabolites from Cistanches Herba by Human Intestinal Bacteria Using UPLC/Q-TOF-MS

Pharmacokinetics of Oral Administration of 2, 3, 5, 4'-Tetrahydroxystilbene-2-o-β-d-glucoside from Polygonum Multiflorum in Beagle Dogs

Pharmacokinetic and Relative Bioavailability of Three Secoiridoid Glycosides in Beagle Dog Plasma after Oral Administration of Conventional and Enteric-Coated Capsules of Gentianella Acuta Extract

An Optimized and Sensitive Pharmacokinetic Quantitative Method of Investigating Gastrodin, Parishin, and Parishin B, C and E in Beagle Dog Plasma using LC-MS/MS after Intragastric Administration of Tall Gastrodia Capsules

An Integrated Approach to Characterize Intestinal Metabolites of Four Phenylethanoid Glycosides and Intestinal Microbe-Mediated Antioxidant Activity Evaluation in Vitro Using UHPLC-Q-Exactive High-Resolution Mass Spectrometry and a 1,1-Diphenyl-2-picrylhydrazyl-based Assay.

Pharmacokinetics of genistein in beagle dogs]

Analysis and pharmacokinetics studies of gastrodin and p-hydroxybenzyl alcohol in dogs using ultra fast liquid chromatography-tandem mass spectrometry method.

Pharmacokinetics of Ginkgo Flavones in Ginkgo Leaf Tablets in Beagle Dogs

Pharmacokinetic Properties of Ephedrine, Amygdalin and Glycyrrhizic Acid after Oral Gavage of San-Ao-Decoction in Beagle Dogs Using A Uplc-Ms Method

[Dose-dependent pharmacokinetic study of genistein in Beagle dogs].

Simultaneous Determination of Four Bioactive Flavonoids from Polygonum Orientale L. in Dog Plasma by Uplc-Esi-Ms/Ms and Application of the Technique to Pharmacokinetic Studies

A Target‐group‐change Couple with Mass Defect Filtering Strategy to Identify the Metabolites of “dogel Ebs” in Rats Plasma, Urine and Bile

Determination of Paeonol in Beagle Dog's Plasma Administered with Guizhi Fuling Capsule by HPLC and Pharmacokinetic Studies

Simultaneous Determination of Plasma Ginkgolide A and B by Gas Chromatography-Mass Spectrometry and the Pharmacokinetics in Beagle Dogs

Sensitive and selective liquid chromatography-electrospray ionization mass spectrometry analysis of ginkgolide B in dog plasma.

Determination of glycyrrhizin in dog plasma by liquid chromatography-mass spectrometry and its application in pharmacokinetic studies.

An ultra-high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous quantitation of 10 alkaloids of Corydalis Decumbentis Rhizoma preparation in dog plasma and its application to a pharmacokinetic study

A review on the structure and pharmacological activity of phenylethanoid glycosides